Data / Form D filings / RheoTek Medical LLC
RheoTek Medical LLC: Form D filings
RheoTek Medical LLC, a biotechnology company in New York, NY, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on September 6, 2024, reports $1.1 million sold of a $4 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 376 BLEECKER ST, UNIT 2, New York, NY, 10014
- Phone
- (203) 494-2369
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1989178
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Amendment | $4,000,000 | $1,085,000 | $2,915,000 | 15 | Aug 31, 2023 | sec.gov |
| Sep 12, 2023 | New notice | $4,000,000 | $1,060,000 | $2,940,000 | 14 | Aug 31, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Mazzaferro | Executive Officer, Director | |
| Scott Bartlett | Executive Officer, Director | |
| Steven Duddy | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 2, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RheoTek Medical LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.